US Stock MarketDetailed Quotes

PMVP PMV Pharmaceuticals

Watchlist

1.820
+0.030+1.68%

Close May 31 16:00 ET

93.63MMarket Cap-1378P/E (TTM)

PMV Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-7.81%-16.18M

12.71%-55.66M

21.14%-12.09M

6.56%-15.66M

5.69%-12.9M

16.59%-15.01M

-36.91%-63.76M

-27.40%-15.32M

-35.18%-16.76M

-48.03%-13.68M

Net income from continuing operations

20.17%-15.27M

5.94%-68.96M

18.55%-15.76M

8.72%-16.64M

-0.73%-17.44M

-3.77%-19.13M

-26.75%-73.32M

-5.37%-19.35M

-21.44%-18.23M

-34.46%-17.31M

Depreciation and amortization

111.70%362K

299.05%1.26M

378.67%359K

383.78%358K

350.00%369K

103.57%171K

2.61%315K

-2.60%75K

-7.50%74K

15.49%82K

Other non cash items

6.67%-84K

-252.26%-370K

-210.13%-87K

-231.94%-95K

-1,188.89%-98K

-208.43%-90K

-74.55%243K

-75.91%79K

-77.00%72K

--9K

Change In working capital

-219.78%-2.17M

1,055.46%5.43M

72.11%2.31M

14.73%-764K

117.68%2.07M

192.46%1.82M

-113.78%-568K

-67.04%1.34M

-401.68%-896K

-50.85%950K

-Change in prepaid assets

-108.02%-169K

194.20%1.72M

-368.12%-984K

97.30%-51K

5.52%650K

328.14%2.11M

-4,913.16%-1.83M

-79.39%367K

-60.95%-1.89M

62.96%616K

-Change in payables and accrued expense

-584.30%-2.01M

267.86%2.87M

739.32%2.46M

-171.80%-713K

388.21%1.42M

83.95%-293K

-141.81%-1.71M

-116.79%-384K

-32.45%993K

-131.64%-492K

-Change in other current liabilities

----

-71.81%837K

----

--2.97M

----

-Change in other working capital

----

---1K

--826K

Cash from discontinued investing activities

Operating cash flow

-7.81%-16.18M

12.71%-55.66M

21.14%-12.09M

6.56%-15.66M

5.69%-12.9M

16.59%-15.01M

-36.91%-63.76M

-27.40%-15.32M

-35.18%-16.76M

-48.03%-13.68M

Investing cash flow

Cash flow from continuing investing activities

-47.29%26.17M

-3,594.81%-50.55M

-111.14%-2.59M

-213.98%-33.64M

-318.63%-63.96M

227.87%49.65M

99.05%-1.37M

207.22%23.22M

4,358.73%29.51M

-44.78%-15.28M

Net PPE purchase and sale

-280.77%-594K

87.95%-962K

87.97%-197K

97.85%-44K

83.86%-565K

80.40%-156K

-491.85%-7.98M

-525.19%-1.64M

-309.18%-2.05M

-651.07%-3.5M

Net investment purchase and sale

-46.27%26.76M

-849.44%-49.58M

-109.62%-2.39M

-206.44%-33.6M

-438.23%-63.4M

230.96%49.8M

104.65%6.62M

217.87%24.86M

16,539.06%31.56M

-16.77%-11.78M

Cash from discontinued investing activities

Investing cash flow

-47.29%26.17M

-3,594.81%-50.55M

-111.14%-2.59M

-213.98%-33.64M

-318.63%-63.96M

227.87%49.65M

99.05%-1.37M

207.22%23.22M

4,358.73%29.51M

-44.78%-15.28M

Financing cash flow

Cash flow from continuing financing activities

3,613.67%35.58M

-47.45%288K

552,333.33%33.15M

672.10%2.13M

-90.63%12K

-52.62%958K

85.76%548K

-98.06%6K

-78.03%276K

Net common stock issuance

----

--35.12M

--0

--33.1M

----

--0

----

Proceeds from stock option exercised by employees

--0

-52.40%456K

-47.45%288K

750.00%51K

-61.96%105K

-90.63%12K

-52.62%958K

85.76%548K

-98.06%6K

-78.03%276K

Cash from discontinued financing activities

Financing cash flow

--0

3,613.67%35.58M

-47.45%288K

552,333.33%33.15M

672.10%2.13M

-90.63%12K

-52.62%958K

85.76%548K

-98.06%6K

-78.03%276K

Net cash flow

Beginning cash position

-64.69%38.53M

-37.03%109.12M

-47.47%52.88M

-21.48%69.03M

23.30%143.76M

-37.03%109.12M

-52.05%173.29M

-43.27%100.67M

-53.79%87.91M

-44.16%116.59M

Current changes in cash

-71.19%9.98M

-10.06%-70.63M

-270.30%-14.39M

-226.58%-16.15M

-160.56%-74.73M

161.11%34.65M

65.89%-64.17M

302.37%8.45M

199.83%12.76M

-54.72%-28.68M

Effect of exchange rate changes

---34K

--34K

----

--0

----

End cash Position

-66.28%48.48M

-64.69%38.53M

-47.47%52.88M

-21.48%69.03M

23.30%143.76M

-37.03%109.12M

-43.27%100.67M

-53.79%87.91M

Free cash flow

-10.61%-16.78M

21.08%-56.62M

27.59%-12.28M

16.51%-15.7M

21.61%-13.47M

19.29%-15.17M

-49.72%-71.74M

-38.01%-16.96M

-45.82%-18.81M

-76.98%-17.18M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-7.81%-16.18M	12.71%-55.66M	21.14%-12.09M	6.56%-15.66M	5.69%-12.9M	16.59%-15.01M	-36.91%-63.76M	-27.40%-15.32M	-35.18%-16.76M	-48.03%-13.68M
Net income from continuing operations	20.17%-15.27M	5.94%-68.96M	18.55%-15.76M	8.72%-16.64M	-0.73%-17.44M	-3.77%-19.13M	-26.75%-73.32M	-5.37%-19.35M	-21.44%-18.23M	-34.46%-17.31M
Depreciation and amortization	111.70%362K	299.05%1.26M	378.67%359K	383.78%358K	350.00%369K	103.57%171K	2.61%315K	-2.60%75K	-7.50%74K	15.49%82K
Other non cash items	6.67%-84K	-252.26%-370K	-210.13%-87K	-231.94%-95K	-1,188.89%-98K	-208.43%-90K	-74.55%243K	-75.91%79K	-77.00%72K	--9K
Change In working capital	-219.78%-2.17M	1,055.46%5.43M	72.11%2.31M	14.73%-764K	117.68%2.07M	192.46%1.82M	-113.78%-568K	-67.04%1.34M	-401.68%-896K	-50.85%950K
-Change in prepaid assets	-108.02%-169K	194.20%1.72M	-368.12%-984K	97.30%-51K	5.52%650K	328.14%2.11M	-4,913.16%-1.83M	-79.39%367K	-60.95%-1.89M	62.96%616K
-Change in payables and accrued expense	-584.30%-2.01M	267.86%2.87M	739.32%2.46M	-171.80%-713K	388.21%1.42M	83.95%-293K	-141.81%-1.71M	-116.79%-384K	-32.45%993K	-131.64%-492K
-Change in other current liabilities	----	-71.81%837K	----	----	----	----	--2.97M	----	----	----
-Change in other working capital	----	----	----	----	----	----	----	----	---1K	--826K
Cash from discontinued investing activities
Operating cash flow	-7.81%-16.18M	12.71%-55.66M	21.14%-12.09M	6.56%-15.66M	5.69%-12.9M	16.59%-15.01M	-36.91%-63.76M	-27.40%-15.32M	-35.18%-16.76M	-48.03%-13.68M
Investing cash flow
Cash flow from continuing investing activities	-47.29%26.17M	-3,594.81%-50.55M	-111.14%-2.59M	-213.98%-33.64M	-318.63%-63.96M	227.87%49.65M	99.05%-1.37M	207.22%23.22M	4,358.73%29.51M	-44.78%-15.28M
Net PPE purchase and sale	-280.77%-594K	87.95%-962K	87.97%-197K	97.85%-44K	83.86%-565K	80.40%-156K	-491.85%-7.98M	-525.19%-1.64M	-309.18%-2.05M	-651.07%-3.5M
Net investment purchase and sale	-46.27%26.76M	-849.44%-49.58M	-109.62%-2.39M	-206.44%-33.6M	-438.23%-63.4M	230.96%49.8M	104.65%6.62M	217.87%24.86M	16,539.06%31.56M	-16.77%-11.78M
Cash from discontinued investing activities
Investing cash flow	-47.29%26.17M	-3,594.81%-50.55M	-111.14%-2.59M	-213.98%-33.64M	-318.63%-63.96M	227.87%49.65M	99.05%-1.37M	207.22%23.22M	4,358.73%29.51M	-44.78%-15.28M
Financing cash flow
Cash flow from continuing financing activities	0	3,613.67%35.58M	-47.45%288K	552,333.33%33.15M	672.10%2.13M	-90.63%12K	-52.62%958K	85.76%548K	-98.06%6K	-78.03%276K
Net common stock issuance	----	--35.12M	--0	--33.1M	----	----	--0	--0	--0	----
Proceeds from stock option exercised by employees	--0	-52.40%456K	-47.45%288K	750.00%51K	-61.96%105K	-90.63%12K	-52.62%958K	85.76%548K	-98.06%6K	-78.03%276K
Cash from discontinued financing activities
Financing cash flow	--0	3,613.67%35.58M	-47.45%288K	552,333.33%33.15M	672.10%2.13M	-90.63%12K	-52.62%958K	85.76%548K	-98.06%6K	-78.03%276K
Net cash flow
Beginning cash position	-64.69%38.53M	-37.03%109.12M	-47.47%52.88M	-21.48%69.03M	23.30%143.76M	-37.03%109.12M	-52.05%173.29M	-43.27%100.67M	-53.79%87.91M	-44.16%116.59M
Current changes in cash	-71.19%9.98M	-10.06%-70.63M	-270.30%-14.39M	-226.58%-16.15M	-160.56%-74.73M	161.11%34.65M	65.89%-64.17M	302.37%8.45M	199.83%12.76M	-54.72%-28.68M
Effect of exchange rate changes	---34K	--34K	----	----	----	----	--0	----	----	----
End cash Position	-66.28%48.48M	-64.69%38.53M	-64.69%38.53M	-47.47%52.88M	-21.48%69.03M	23.30%143.76M	-37.03%109.12M	-37.03%109.12M	-43.27%100.67M	-53.79%87.91M
Free cash flow	-10.61%-16.78M	21.08%-56.62M	27.59%-12.28M	16.51%-15.7M	21.61%-13.47M	19.29%-15.17M	-49.72%-71.74M	-38.01%-16.96M	-45.82%-18.81M	-76.98%-17.18M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall